Patient | Initial Diagnosis* | Level Before Treatment | Clinical Diagnosis After Treatment | Clinical Assessment After Treatment‖ | Level After Treatment | ||||
---|---|---|---|---|---|---|---|---|---|
T4 (nmol/L)† | T3 (pmol/L)‡ | TSH (mU/L)§ | T4 (nmol/L)† | T3 (pmol/L)‡ | TSH (mU/L)§ | ||||
1 | Hyperthyroidism | 284 | 32.2 | <0.1 | Euthyroidism | Symptoms remitted | 116 | 7.8 | <0.1 |
2 | Hyperthyroidism | 267 | 23+ | <0.1 | Euthyroidism | Symptoms remitted | 61 | 2.2+ | <0.1 |
3 | Hyperthyroidism | 263 | 13.2+ | <0.1 | Euthyroidism | Symptoms remitted | 112 | 4.6+ | <0.1 |
4 | Hyperthyroidism | 196 | 28.2 | <0.1 | Euthyroidism | Symptoms remitted | 73 | 7.2 | <0.1 |
5 | Hyperthyroidism | 142 | 11.1 | <0.1 | Euthyroidism | Symptoms remitted | 53 | 2.8+ | <0.1 |
6 | Hyperthyroidism | 287 | 39.7+ | <0.1 | Euthyroidism | Symptoms remitted | 121 | 6.1+ | 1.4 |
7 | Hyperthyroidism | >300 | 55.9 | <0.1 | Euthyroidism | Symptoms remitted | 66 | 6.2 | <0.1 |
8 | Hyperthyroidism | 307 | >45 | <0.1 | Toxicity | Symptoms remitted | 229 | 20.4 | <0.1 |
9 | Hypothyroidism | 2 | 2.9 | 43.3 | Euthyroidism | Symptoms remitted | 81 | 6.9 | 2.5 |
10 | Hypothyroidism | <15 | NA | 76.5 | Euthyroidism | Symptoms remitted | 94 | NA | 3.4 |
11 | Hypothyroidism | <15 | NA | >100 | Euthyroidism | Symptoms remitted | 113 | NA | 25.9 |
* All patients with hyperthyroidism had neuropsychological symptoms of anxiety, agitation, restlessness, and hyperactivity. All patients with hypothyroidism had neuropsychological symptoms of tiredness, lethargy, mental slowing, and depression.
† Normal range, 60–160 nmol/L.
‡ Normal ranges, 5.4–9.3 pmol/L (assay 1) and 2.5–5.3 pmol/L (assay 2) (denoted with +).
§ Normal range, 0.4–4.0 mU/L.
‖ In all patients, symptoms remitted at clinical assessment after treatment.